PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: ketan.badani@mountsinai.org.\', \'Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Natasha.Kyprianou@mountsinai.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2405-4569(20)30160-710.1016/j.euf.2020.06.002
?:doi
?:hasPublicationType
?:journal
  • European urology focus
is ?:pmid of
?:pmid
?:pmid
  • 32540268
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.663
?:rankingScore_hIndex
  • 6
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all